aluates Reports

$ 0.0

Automative

Global Apomorphine Hydrochloride Injection Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-21E8546

Global Apomorphine Hydrochloride Injection Market Insights and Forecast to 2028

BUY CHAPTERS

Global Apomorphine Hydrochloride Injection Market Research Report 2024

Code: QYRE-Auto-21E8546

Report

January 2024

Pages:74

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Supernus Pharmaceuticals

Britannia Pharmaceuticals STADA

EVER Pharma

Evolan Pharma AB (PharmSwed)

Apomorphine Hydrochloride Injection Market Size

The global Apomorphine Hydrochloride Injection market was valued at US$ 249 million in 2023 and is anticipated to reach US$ 327.3 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.

Apomorphine Hydrochloride Injection Market

Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.

The classification of Apomorphine Hydrochloride includes Injection, Tablets, Thinfilm, etc and the proportion of Injection in 2019 is about 89.88%, and the proportion is in decreasing trend from 2020 to 2025.

Apomorphine Hydrochloride is widely used through Parkinson Disease and Erectile Dysfunction. The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%.

Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 23.69%.

Market competition is not intense. Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

This report aims to provide a comprehensive presentation of the global market for Apomorphine Hydrochloride Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Apomorphine Hydrochloride Injection.

Report Scope

The Apomorphine Hydrochloride Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Apomorphine Hydrochloride Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Apomorphine Hydrochloride Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Apomorphine Hydrochloride Injection Market Report

Report Metric	Details
Report Name	Apomorphine Hydrochloride Injection Market
Accounted market size in 2023	US$ 249 million
Forecasted market size in 2030	US$ 327.3 million
CAGR	3.9%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Pen Injectors Infusion Pumps
Segment by Application	Parkinson Disease Erectile Dysfunction
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma, Evolan Pharma AB (PharmSwed)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Apomorphine Hydrochloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Apomorphine Hydrochloride Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Apomorphine Hydrochloride Injection Market growing?

Ans: The Apomorphine Hydrochloride Injection Market witnessing a CAGR of 3.9% during the forecast period 2024-2030.

What is the Apomorphine Hydrochloride Injection Market size in 2030?

Ans: The Apomorphine Hydrochloride Injection Market size in 2030 will be US$ 327.3 million.

What is the Apomorphine Hydrochloride Injection Market share by application?

Ans: The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%.

What is the Apomorphine Hydrochloride Injection Market share by region?

Ans: Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019.

Who are the main players in the Apomorphine Hydrochloride Injection Market report?

Ans: The main players in the Apomorphine Hydrochloride Injection Market are Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma, Evolan Pharma AB (PharmSwed)

What are the Application segmentation covered in the Apomorphine Hydrochloride Injection Market report?

Ans: The Applications covered in the Apomorphine Hydrochloride Injection Market report are Parkinson Disease, Erectile Dysfunction

What are the Type segmentation covered in the Apomorphine Hydrochloride Injection Market report?

Ans: The Types covered in the Apomorphine Hydrochloride Injection Market report are Pen Injectors, Infusion Pumps

1 Apomorphine Hydrochloride Injection Market Overview

1.1 Product Overview and Scope of Apomorphine Hydrochloride Injection

1.2 Apomorphine Hydrochloride Injection Segment by Type

1.2.1 Global Apomorphine Hydrochloride Injection Market Value Comparison by Type (2024-2030)

1.2.2 Pen Injectors

1.2.3 Infusion Pumps

1.3 Apomorphine Hydrochloride Injection Segment by Application

1.3.1 Global Apomorphine Hydrochloride Injection Market Value by Application: (2024-2030)

1.3.2 Parkinson Disease

1.3.3 Erectile Dysfunction

1.4 Global Apomorphine Hydrochloride Injection Market Size Estimates and Forecasts

1.4.1 Global Apomorphine Hydrochloride Injection Revenue 2019-2030

1.4.2 Global Apomorphine Hydrochloride Injection Sales 2019-2030

1.4.3 Global Apomorphine Hydrochloride Injection Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Apomorphine Hydrochloride Injection Market Competition by Manufacturers

2.1 Global Apomorphine Hydrochloride Injection Sales Market Share by Manufacturers (2019-2024)

2.2 Global Apomorphine Hydrochloride Injection Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Apomorphine Hydrochloride Injection Average Price by Manufacturers (2019-2024)

2.4 Global Apomorphine Hydrochloride Injection Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Apomorphine Hydrochloride Injection, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Apomorphine Hydrochloride Injection, Product Type & Application

2.7 Apomorphine Hydrochloride Injection Market Competitive Situation and Trends

2.7.1 Apomorphine Hydrochloride Injection Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Apomorphine Hydrochloride Injection Players Market Share by Revenue

2.7.3 Global Apomorphine Hydrochloride Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Apomorphine Hydrochloride Injection Retrospective Market Scenario by Region

3.1 Global Apomorphine Hydrochloride Injection Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Apomorphine Hydrochloride Injection Global Apomorphine Hydrochloride Injection Sales by Region: 2019-2030

3.2.1 Global Apomorphine Hydrochloride Injection Sales by Region: 2019-2024

3.2.2 Global Apomorphine Hydrochloride Injection Sales by Region: 2025-2030

3.3 Global Apomorphine Hydrochloride Injection Global Apomorphine Hydrochloride Injection Revenue by Region: 2019-2030

3.3.1 Global Apomorphine Hydrochloride Injection Revenue by Region: 2019-2024

3.3.2 Global Apomorphine Hydrochloride Injection Revenue by Region: 2025-2030

3.4 North America Apomorphine Hydrochloride Injection Market Facts & Figures by Country

3.4.1 North America Apomorphine Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Apomorphine Hydrochloride Injection Sales by Country (2019-2030)

3.4.3 North America Apomorphine Hydrochloride Injection Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Apomorphine Hydrochloride Injection Market Facts & Figures by Country

3.5.1 Europe Apomorphine Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Apomorphine Hydrochloride Injection Sales by Country (2019-2030)

3.5.3 Europe Apomorphine Hydrochloride Injection Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Apomorphine Hydrochloride Injection Market Facts & Figures by Country

3.6.1 Asia Pacific Apomorphine Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Apomorphine Hydrochloride Injection Sales by Country (2019-2030)

3.6.3 Asia Pacific Apomorphine Hydrochloride Injection Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Apomorphine Hydrochloride Injection Market Facts & Figures by Country

3.7.1 Latin America Apomorphine Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Apomorphine Hydrochloride Injection Sales by Country (2019-2030)

3.7.3 Latin America Apomorphine Hydrochloride Injection Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Apomorphine Hydrochloride Injection Market Facts & Figures by Country

3.8.1 Middle East and Africa Apomorphine Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Apomorphine Hydrochloride Injection Sales by Country (2019-2030)

3.8.3 Middle East and Africa Apomorphine Hydrochloride Injection Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Apomorphine Hydrochloride Injection Sales by Type (2019-2030)

4.1.1 Global Apomorphine Hydrochloride Injection Sales by Type (2019-2024)

4.1.2 Global Apomorphine Hydrochloride Injection Sales by Type (2025-2030)

4.1.3 Global Apomorphine Hydrochloride Injection Sales Market Share by Type (2019-2030)

4.2 Global Apomorphine Hydrochloride Injection Revenue by Type (2019-2030)

4.2.1 Global Apomorphine Hydrochloride Injection Revenue by Type (2019-2024)

4.2.2 Global Apomorphine Hydrochloride Injection Revenue by Type (2025-2030)

4.2.3 Global Apomorphine Hydrochloride Injection Revenue Market Share by Type (2019-2030)

4.3 Global Apomorphine Hydrochloride Injection Price by Type (2019-2030)

5 Segment by Application

5.1 Global Apomorphine Hydrochloride Injection Sales by Application (2019-2030)

5.1.1 Global Apomorphine Hydrochloride Injection Sales by Application (2019-2024)

5.1.2 Global Apomorphine Hydrochloride Injection Sales by Application (2025-2030)

5.1.3 Global Apomorphine Hydrochloride Injection Sales Market Share by Application (2019-2030)

5.2 Global Apomorphine Hydrochloride Injection Revenue by Application (2019-2030)

5.2.1 Global Apomorphine Hydrochloride Injection Revenue by Application (2019-2024)

5.2.2 Global Apomorphine Hydrochloride Injection Revenue by Application (2025-2030)

5.2.3 Global Apomorphine Hydrochloride Injection Revenue Market Share by Application (2019-2030)

5.3 Global Apomorphine Hydrochloride Injection Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Supernus Pharmaceuticals

6.1.1 Supernus Pharmaceuticals Corporation Information

6.1.2 Supernus Pharmaceuticals Description and Business Overview

6.1.3 Supernus Pharmaceuticals Apomorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Supernus Pharmaceuticals Apomorphine Hydrochloride Injection Product Portfolio

6.1.5 Supernus Pharmaceuticals Recent Developments/Updates

6.2 Britannia Pharmaceuticals STADA

6.2.1 Britannia Pharmaceuticals STADA Corporation Information

6.2.2 Britannia Pharmaceuticals STADA Description and Business Overview

6.2.3 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Injection Product Portfolio

6.2.5 Britannia Pharmaceuticals STADA Recent Developments/Updates

6.3 Ever Pharma

6.3.1 Ever Pharma Corporation Information

6.3.2 Ever Pharma Description and Business Overview

6.3.3 Ever Pharma Apomorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Ever Pharma Apomorphine Hydrochloride Injection Product Portfolio

6.3.5 Ever Pharma Recent Developments/Updates

6.4 Evolan Pharma AB (PharmSwed)

6.4.1 Evolan Pharma AB (PharmSwed) Corporation Information

6.4.2 Evolan Pharma AB (PharmSwed) Description and Business Overview

6.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Injection Product Portfolio

6.4.5 Evolan Pharma AB (PharmSwed) Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Apomorphine Hydrochloride Injection Industry Chain Analysis

7.2 Apomorphine Hydrochloride Injection Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Apomorphine Hydrochloride Injection Production Mode & Process

7.4 Apomorphine Hydrochloride Injection Sales and Marketing

7.4.1 Apomorphine Hydrochloride Injection Sales Channels

7.4.2 Apomorphine Hydrochloride Injection Distributors

7.5 Apomorphine Hydrochloride Injection Customers

8 Apomorphine Hydrochloride Injection Market Dynamics

8.1 Apomorphine Hydrochloride Injection Industry Trends

8.2 Apomorphine Hydrochloride Injection Market Drivers

8.3 Apomorphine Hydrochloride Injection Market Challenges

8.4 Apomorphine Hydrochloride Injection Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Supernus Pharmaceuticals

Britannia Pharmaceuticals STADA

EVER Pharma

Evolan Pharma AB (PharmSwed)

List of Tables

Table 1. Global Apomorphine Hydrochloride Injection Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Apomorphine Hydrochloride Injection Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Apomorphine Hydrochloride Injection Market Competitive Situation by Manufacturers in 2023

Table 4. Global Apomorphine Hydrochloride Injection Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Apomorphine Hydrochloride Injection Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Apomorphine Hydrochloride Injection Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Apomorphine Hydrochloride Injection Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Apomorphine Hydrochloride Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Apomorphine Hydrochloride Injection, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Apomorphine Hydrochloride Injection, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Apomorphine Hydrochloride Injection, Product Type & Application

Table 12. Global Key Manufacturers of Apomorphine Hydrochloride Injection, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Apomorphine Hydrochloride Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Apomorphine Hydrochloride Injection as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Apomorphine Hydrochloride Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Apomorphine Hydrochloride Injection Sales by Region (2019-2024) & (K Units)

Table 18. Global Apomorphine Hydrochloride Injection Sales Market Share by Region (2019-2024)

Table 19. Global Apomorphine Hydrochloride Injection Sales by Region (2025-2030) & (K Units)

Table 20. Global Apomorphine Hydrochloride Injection Sales Market Share by Region (2025-2030)

Table 21. Global Apomorphine Hydrochloride Injection Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Apomorphine Hydrochloride Injection Revenue Market Share by Region (2019-2024)

Table 23. Global Apomorphine Hydrochloride Injection Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Apomorphine Hydrochloride Injection Revenue Market Share by Region (2025-2030)

Table 25. North America Apomorphine Hydrochloride Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Apomorphine Hydrochloride Injection Sales by Country (2019-2024) & (K Units)

Table 27. North America Apomorphine Hydrochloride Injection Sales by Country (2025-2030) & (K Units)

Table 28. North America Apomorphine Hydrochloride Injection Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Apomorphine Hydrochloride Injection Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Apomorphine Hydrochloride Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Apomorphine Hydrochloride Injection Sales by Country (2019-2024) & (K Units)

Table 32. Europe Apomorphine Hydrochloride Injection Sales by Country (2025-2030) & (K Units)

Table 33. Europe Apomorphine Hydrochloride Injection Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Apomorphine Hydrochloride Injection Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Apomorphine Hydrochloride Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Apomorphine Hydrochloride Injection Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Apomorphine Hydrochloride Injection Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Apomorphine Hydrochloride Injection Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Apomorphine Hydrochloride Injection Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Apomorphine Hydrochloride Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Apomorphine Hydrochloride Injection Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Apomorphine Hydrochloride Injection Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Apomorphine Hydrochloride Injection Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Apomorphine Hydrochloride Injection Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Apomorphine Hydrochloride Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Apomorphine Hydrochloride Injection Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Apomorphine Hydrochloride Injection Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Apomorphine Hydrochloride Injection Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Apomorphine Hydrochloride Injection Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Apomorphine Hydrochloride Injection Sales (K Units) by Type (2019-2024)

Table 51. Global Apomorphine Hydrochloride Injection Sales (K Units) by Type (2025-2030)

Table 52. Global Apomorphine Hydrochloride Injection Sales Market Share by Type (2019-2024)

Table 53. Global Apomorphine Hydrochloride Injection Sales Market Share by Type (2025-2030)

Table 54. Global Apomorphine Hydrochloride Injection Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Apomorphine Hydrochloride Injection Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Apomorphine Hydrochloride Injection Revenue Market Share by Type (2019-2024)

Table 57. Global Apomorphine Hydrochloride Injection Revenue Market Share by Type (2025-2030)

Table 58. Global Apomorphine Hydrochloride Injection Price (US$/Unit) by Type (2019-2024)

Table 59. Global Apomorphine Hydrochloride Injection Price (US$/Unit) by Type (2025-2030)

Table 60. Global Apomorphine Hydrochloride Injection Sales (K Units) by Application (2019-2024)

Table 61. Global Apomorphine Hydrochloride Injection Sales (K Units) by Application (2025-2030)

Table 62. Global Apomorphine Hydrochloride Injection Sales Market Share by Application (2019-2024)

Table 63. Global Apomorphine Hydrochloride Injection Sales Market Share by Application (2025-2030)

Table 64. Global Apomorphine Hydrochloride Injection Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Apomorphine Hydrochloride Injection Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Apomorphine Hydrochloride Injection Revenue Market Share by Application (2019-2024)

Table 67. Global Apomorphine Hydrochloride Injection Revenue Market Share by Application (2025-2030)

Table 68. Global Apomorphine Hydrochloride Injection Price (US$/Unit) by Application (2019-2024)

Table 69. Global Apomorphine Hydrochloride Injection Price (US$/Unit) by Application (2025-2030)

Table 70. Supernus Pharmaceuticals Corporation Information

Table 71. Supernus Pharmaceuticals Description and Business Overview

Table 72. Supernus Pharmaceuticals Apomorphine Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Supernus Pharmaceuticals Apomorphine Hydrochloride Injection Product

Table 74. Supernus Pharmaceuticals Recent Developments/Updates

Table 75. Britannia Pharmaceuticals STADA Corporation Information

Table 76. Britannia Pharmaceuticals STADA Description and Business Overview

Table 77. Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Injection Product

Table 79. Britannia Pharmaceuticals STADA Recent Developments/Updates

Table 80. Ever Pharma Corporation Information

Table 81. Ever Pharma Description and Business Overview

Table 82. Ever Pharma Apomorphine Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Ever Pharma Apomorphine Hydrochloride Injection Product

Table 84. Ever Pharma Recent Developments/Updates

Table 85. Evolan Pharma AB (PharmSwed) Corporation Information

Table 86. Evolan Pharma AB (PharmSwed) Description and Business Overview

Table 87. Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Injection Product

Table 89. Evolan Pharma AB (PharmSwed) Recent Developments/Updates

Table 90. Key Raw Materials Lists

Table 91. Raw Materials Key Suppliers Lists

Table 92. Apomorphine Hydrochloride Injection Distributors List

Table 93. Apomorphine Hydrochloride Injection Customers List

Table 94. Apomorphine Hydrochloride Injection Market Trends

Table 95. Apomorphine Hydrochloride Injection Market Drivers

Table 96. Apomorphine Hydrochloride Injection Market Challenges

Table 97. Apomorphine Hydrochloride Injection Market Restraints

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Apomorphine Hydrochloride Injection

Figure 2. Global Apomorphine Hydrochloride Injection Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Apomorphine Hydrochloride Injection Market Share by Type in 2023 & 2030

Figure 4. Pen Injectors Product Picture

Figure 5. Infusion Pumps Product Picture

Figure 6. Global Apomorphine Hydrochloride Injection Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Apomorphine Hydrochloride Injection Market Share by Application in 2023 & 2030

Figure 8. Parkinson Disease

Figure 9. Erectile Dysfunction

Figure 10. Global Apomorphine Hydrochloride Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 11. Global Apomorphine Hydrochloride Injection Market Size (2019-2030) & (US$ Million)

Figure 12. Global Apomorphine Hydrochloride Injection Sales (2019-2030) & (K Units)

Figure 13. Global Apomorphine Hydrochloride Injection Average Price (US$/Unit) & (2019-2030)

Figure 14. Apomorphine Hydrochloride Injection Report Years Considered

Figure 15. Apomorphine Hydrochloride Injection Sales Share by Manufacturers in 2023

Figure 16. Global Apomorphine Hydrochloride Injection Revenue Share by Manufacturers in 2023

Figure 17. The Global 5 and 10 Largest Apomorphine Hydrochloride Injection Players: Market Share by Revenue in 2023

Figure 18. Apomorphine Hydrochloride Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 19. Global Apomorphine Hydrochloride Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 20. North America Apomorphine Hydrochloride Injection Sales Market Share by Country (2019-2030)

Figure 21. North America Apomorphine Hydrochloride Injection Revenue Market Share by Country (2019-2030)

Figure 22. U.S. Apomorphine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 23. Canada Apomorphine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Europe Apomorphine Hydrochloride Injection Sales Market Share by Country (2019-2030)

Figure 25. Europe Apomorphine Hydrochloride Injection Revenue Market Share by Country (2019-2030)

Figure 26. Germany Apomorphine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. France Apomorphine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. U.K. Apomorphine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Italy Apomorphine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Russia Apomorphine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Apomorphine Hydrochloride Injection Sales Market Share by Region (2019-2030)

Figure 32. Asia Pacific Apomorphine Hydrochloride Injection Revenue Market Share by Region (2019-2030)

Figure 33. China Apomorphine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Japan Apomorphine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. South Korea Apomorphine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. India Apomorphine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Australia Apomorphine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Taiwan Apomorphine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Indonesia Apomorphine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Thailand Apomorphine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Malaysia Apomorphine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Philippines Apomorphine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Latin America Apomorphine Hydrochloride Injection Sales Market Share by Country (2019-2030)

Figure 44. Latin America Apomorphine Hydrochloride Injection Revenue Market Share by Country (2019-2030)

Figure 45. Mexico Apomorphine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Brazil Apomorphine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Argentina Apomorphine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Apomorphine Hydrochloride Injection Sales Market Share by Country (2019-2030)

Figure 49. Middle East & Africa Apomorphine Hydrochloride Injection Revenue Market Share by Country (2019-2030)

Figure 50. Turkey Apomorphine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia Apomorphine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. UAE Apomorphine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Global Sales Market Share of Apomorphine Hydrochloride Injection by Type (2019-2030)

Figure 54. Global Revenue Market Share of Apomorphine Hydrochloride Injection by Type (2019-2030)

Figure 55. Global Apomorphine Hydrochloride Injection Price (US$/Unit) by Type (2019-2030)

Figure 56. Global Sales Market Share of Apomorphine Hydrochloride Injection by Application (2019-2030)

Figure 57. Global Revenue Market Share of Apomorphine Hydrochloride Injection by Application (2019-2030)

Figure 58. Global Apomorphine Hydrochloride Injection Price (US$/Unit) by Application (2019-2030)

Figure 59. Apomorphine Hydrochloride Injection Value Chain

Figure 60. Apomorphine Hydrochloride Injection Production Process

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Distributors Profiles

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions